GTC WAS FOUNDED IN 2018
We offer advanced genomic profiling for both solid and hematologic cancers to communities everywhere at an affordable price.
We utilize a cooperative business model to help physicians treat patients locally with the most advanced precision medicine.
We embrace disruptive deep learning and advanced technology to create scalable efficiencies, incomparable precision, and a more personalized approach to patient care.
We are committed to driving the field of oncology forward by enabling more patients to contribute their unique cancer experience to the growing body of cancer genomics data.
We are committed to fulfilling precision medicine’s promise of individualized care for everyone by empowering physicians to formulate treatments that best suit each patient’s unique genetic profile.
Machine / Deep Learning (AI) is the center of our analysis
